Search

everythinglearnresearchcommunity

for

Search:↓

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

Human skin can make serotonin and melatonin, which help protect and maintain it.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Human epidermal neural crest stem cells can become bone and skin pigment cells, making them useful for therapies.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Human hair follicles produce and respond to erythropoietin, helping protect against stress.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Male hormones affect oil-producing skin cells differently based on their body location, and the drug spironolactone can reduce these effects.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Dihydrotestosterone (DHT) stops hair growth in mice by lowering a growth factor important for hair.

Minoxidil may cause heart changes; use caution and monitor patients with heart conditions.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

The research explains how a human enzyme binds and processes its substrate, which could relate to its role in biological functions and hair loss.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Certain genetic variations in OCT1 may improve insulin sensitivity with metformin in women with PCOS.

Women with PCOS have a higher risk of heart disease due to factors like insulin resistance and obesity.

The document explains different hair loss types and treatments, emphasizing diagnosis through examination and tests, and specific treatments for each condition.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Prenatally androgenized ewes can model increased hair diameter in women with PCOS.

Testosterone replacement may help postmenopausal women with sexual function and bone density, but suitable treatments are limited.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Women with PCOS have lower amylin levels, which are not related to their body weight.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

No clear link between pilonidal sinus disease and polycystic ovary syndrome was found.